as on December 20, 2025 at 2:29 am IST
Day's Low
Day's High
4.29%
Downside
4.29%
Upside
52 Week's Low
52 Week's High
23.91%
Downside
642.86%
Upside
Check Purple Biotech Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.8M
EPS (TTM)
-1.16
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-8.56%
Compare market cap, revenue, PE, and other key metrics of Purple Biotech Ltd with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $6.8M | NA | NA | 0.00% | |
| BUY | $37.3B | 371.01% | -16.34 | -264.83% | |
| BUY | $52.3B | 181.08% | 1237.62 | 1.36% | |
| BUY | $114.7B | 92.72% | 31.44 | 31.35% | |
| BUY | $79.4B | 53.93% | 17.95 | 32.13% |
The Purple Biotech Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Purple Biotech Ltd investment value today
Current value as on today
₹25,699
Returns
Returns from Purple Biotech Ltd Stock
Dollar Returns*
₹5,231 (+5.23%)
Search interest for Purple Biotech Ltd Stock has decreased by -51% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 30 October
Thu, 03:08 PM
-PPBT shares dipped 19.1% in pre-market after an 82% jump due to achieving a commercially viable yield for IM1240.
Thu, 09:03 PM
-Purple Biotech's stock surged 81% after announcing a production milestone for IM1240, a tri-specific antibody targeting cancer.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 148.2% return, outperforming this stock by 227.5%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 775.1% return, outperforming this stock by 872.8%
Price Dip
![]()
In the last 6 months, PPBT stock has moved down by -69.2%
| Organisation | Purple Biotech Ltd |
| Headquarters | 4 Oppenheimer Street, Rehovot, Israel, 7670104 |
| CEO | Mr. Gil Efron CPA, M.A. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Michael Schickler Ph.D. | Head of Clinical & Regulatory Affairs |
Mr. Gil Efron CPA, M.A. | Chief Executive Officer |
Purple Biotech Ltd share price today is $0.7 as on at the close of the market. Purple Biotech Ltd share today touched a day high of $0.73 and a low of $0.67.
Purple Biotech Ltd share touched a 52 week high of $5.2 on and a 52 week low of $0.53 on . Purple Biotech Ltd stock price today i.e. is closed at $0.7,which is 86.54% down from its 52 week high and 31.43% up from its 52 week low.
Purple Biotech Ltd market capitalisation is $0.00T as on .
Indian investors can start investing in Purple Biotech Ltd (PPBT) shares with as little as ₹89.552 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹895.52 in Purple Biotech Ltd stock (as per the Rupee-Dollar exchange rate as on ).
Based on Purple Biotech Ltd share’s latest price of $0.7 as on December 20, 2025 at 2:29 am IST, you will get 14.2857 shares of Purple Biotech Ltd. Learn more about
fractional shares .